Shares of Evoke plc (LON:EVOK - Get Free Report) traded down 20.9% during trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 56.50 ($0.73). 8,039,770 shares changed hands during mid-day trading, an increase of 291% from the average session volume of 2,054,730 shares. The stock had previously closed at GBX 71.40 ($0.92).
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. Berenberg Bank cut their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group restated a "buy" rating and set a GBX 140 ($1.81) price target on shares of Evoke in a report on Monday, December 16th.
Read Our Latest Analysis on EVOK
Evoke Stock Performance
The business's fifty day moving average price is GBX 68.88 and its two-hundred day moving average price is GBX 63.49. The stock has a market capitalization of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84.
Evoke (LON:EVOK - Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Buying and Selling at Evoke
In other news, insider Andrea Gisle Joosen acquired 14,572 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company's stock.
About Evoke
(
Get Free Report)
Featured Articles
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
